Tidal Investments LLC grew its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 31.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 61,646 shares of the company’s stock after purchasing an additional 14,631 shares during the quarter. Tidal Investments LLC’s holdings in Colgate-Palmolive were worth $5,551,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in shares of Colgate-Palmolive by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 79,894,344 shares of the company’s stock worth $6,368,378,000 after purchasing an additional 416,853 shares during the period. Price T Rowe Associates Inc. MD increased its stake in shares of Colgate-Palmolive by 27.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after acquiring an additional 8,933,912 shares during the period. Norges Bank purchased a new stake in Colgate-Palmolive in the fourth quarter valued at $731,843,000. GUARDCAP ASSET MANAGEMENT Ltd raised its stake in shares of Colgate-Palmolive by 4.1% during the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company’s stock valued at $629,220,000 after buying an additional 278,150 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Colgate-Palmolive by 1.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,426,430 shares of the company’s stock worth $352,824,000 after buying an additional 77,679 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
CL has been the subject of several analyst reports. TD Cowen boosted their target price on shares of Colgate-Palmolive from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Tuesday. Argus increased their target price on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research note on Wednesday, May 15th. Jefferies Financial Group cut Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their target price for the company from $103.00 to $95.00 in a research report on Wednesday, July 24th. Barclays increased their price target on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research report on Monday. Finally, Evercore ISI upped their target price on Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. Seven analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $101.11.
Insider Activity
In related news, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the sale, the insider now directly owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the sale, the insider now owns 3,181 shares of the company’s stock, valued at $297,328.07. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the transaction, the insider now owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company’s stock.
Colgate-Palmolive Trading Up 0.6 %
Shares of NYSE CL traded up $0.59 during trading on Thursday, hitting $99.78. 1,440,811 shares of the company were exchanged, compared to its average volume of 4,404,379. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.28 and a current ratio of 1.06. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $101.42. The company has a fifty day moving average price of $96.15 and a 200-day moving average price of $90.54. The firm has a market capitalization of $81.53 billion, a PE ratio of 31.39, a P/E/G ratio of 3.52 and a beta of 0.39.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.04. The company had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. Colgate-Palmolive’s revenue was up 4.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.77 EPS. As a group, equities research analysts expect that Colgate-Palmolive will post 3.57 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be given a $0.50 dividend. The ex-dividend date is Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.00%. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- How to Evaluate a Stock Before BuyingÂ
- First Solar Stock: The Dawn of a New Rally in Share Prices
- Transportation Stocks Investing
- Mastercard Stock’s Q2 Financial Results Outshine Competitors
- Want to Profit on the Downtrend? Downtrends, Explained.
- Tobacco Giant’s Shares Fall on EPS Miss, Lackluster Pouch Gains
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.